{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:59:59Z","timestamp":1761487199095,"version":"3.40.5"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"abstract":"\n Objective.<\/jats:title>\n Chronic hepatitis C is a major long-term problem for children who survive cancer. Interferon (IFN)-\u03b1 has been shown to be effective in treating patients with chronic hepatitis C; however, the rate of sustained response is low. Combining IFN-\u03b1 and ribavirin (RBV) has been shown to significantly improve the response in adult patients with chronic hepatitis C. The aim of this pilot study was to evaluate the efficacy and safety of a combined virostatic treatment with IFN-\u03b1 and RBV in a small cohort of children and adolescents with chronic hepatitis C and previous malignancy.<\/jats:p>\n <\/jats:sec>\n \n Methods.<\/jats:title>\n Twelve patients with a history of a hematooncologic disease (median follow-up: 13.5 years; range: 7\u201314.7 years) and chronic hepatitis C were treated with recombinant IFN-\u03b1-2a (6 megaunits\/m2 body surface area, 3 times a week, subcutaneously) combined with RBV (15 mg\/kg body weight\/day, orally) for 12 months. They were tested monthly for blood counts and liver function, and for serum virus concentrations (hepatitis C virus RNA by polymerase chain reaction) every 3 months.<\/jats:p>\n <\/jats:sec>\n \n Results.<\/jats:title>\n At the end of the treatment, hepatitis C virus RNA could not be detected in the serum of 8 of the 12 patients; 2 of these patients relapsed soon after therapy withdrawal, whereas 6 patients maintained in sustained virologic and biochemical remission (follow-up: 12 months). Treatment-induced toxicity was moderate and reversible with influenza-like symptoms and a decrease in blood counts in all 12 patients, alopecia in 5 of the 12, hemolysis in 4 of the 12, and weight loss of &gt;10% in 2 of the 12.<\/jats:p>\n <\/jats:sec>\n \n Conclusions.<\/jats:title>\n As demonstrated in adults with chronic hepatitis C, treatment with IFN-\u03b1 and RBV also seems to be an effective and safe therapeutic option for children and adolescents with chronic hepatitis C after malignancy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.106.4.e53","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"e53-e53","source":"Crossref","is-referenced-by-count":58,"title":["Interferon-\u03b1 and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy"],"prefix":"10.1542","volume":"106","author":[{"given":"Herwig","family":"Lackner","sequence":"first","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Moser","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Deutsch","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald H.","family":"Kessler","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Karl-Franzens-University, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Benesch","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Kerbl","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schwinger","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ju\u0308rgen","family":"Dornbusch","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Preisegger","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Urban","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Hematology\/Oncology, Department of Pediatrics; and the"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2000,10,1]]},"reference":[{"key":"2021121009291030000_B1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood.V90.3.1315.1315_1315_1320","article-title":"Chronic hepatitis C virus infection after treatment for pediatric malignancy.","volume":"90","author":"Cesaro","year":"1997","journal-title":"Blood"},{"key":"2021121009291030000_B2","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1182\/blood.V82.8.2564.2564","article-title":"Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy.","volume":"82","author":"Locasciulli","year":"1993","journal-title":"Blood"},{"key":"2021121009291030000_B3","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1182\/blood.V84.9.2919.2919","article-title":"Hepatitis C virus infection in children treated for acute lymphoblastic leukemia.","volume":"84","author":"Arico\u0300","year":"1994","journal-title":"Blood"},{"key":"2021121009291030000_B4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF01955056","article-title":"Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients.","volume":"152","author":"Fink","year":"1993","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B5","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1182\/blood.V93.11.3672.411k04_3672_3677","article-title":"Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease.","volume":"93","author":"Paul","year":"1999","journal-title":"Blood"},{"key":"2021121009291030000_B6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s004310050637","article-title":"Hepatitis B and C virus infection in Polish children with malignancies.","volume":"156","author":"Januszkiewicz","year":"1997","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B7","first-page":"271","article-title":"Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia.","volume":"153","author":"Dibenedetto","year":"1994","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s004310050710","article-title":"Spontaneous remission of chronic hepatitis C in children.","volume":"156","author":"Fujisawa","year":"1997","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","article-title":"Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.","volume":"341","author":"Vogt","year":"1999","journal-title":"N Engl J Med"},{"key":"2021121009291030000_B10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00008480-199710000-00012","article-title":"Hepatitis C virus in infants and children.","volume":"9","author":"Thaler","year":"1997","journal-title":"Curr Opin Pediatr"},{"key":"2021121009291030000_B11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.510280534","article-title":"Histopathology of the liver in children with chronic hepatitis C viral infection.","volume":"28","author":"Badizadegan","year":"1998","journal-title":"Hepatology"},{"key":"2021121009291030000_B12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-129-2-199807150-00005","article-title":"Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C.","volume":"129","author":"Imai","year":"1998","journal-title":"Ann Intern Med"},{"key":"2021121009291030000_B13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0168-8278(97)80103-1","article-title":"Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C.","volume":"26","author":"Schalm","year":"1997","journal-title":"J Hepatol"},{"key":"2021121009291030000_B14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00005176-199608000-00001","article-title":"Interferon-\u03b1 for viral hepatitis.","volume":"23","author":"Jonas","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021121009291030000_B15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/hep.1840160405","article-title":"Treatment of children with chronic hepatitis C with recombinant interferon-\u03b1: a pilot study.","volume":"16","author":"Ruiz-Moreno","year":"1992","journal-title":"Hepatology"},{"key":"2021121009291030000_B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02190687","article-title":"Interferon for chronic hepatitis C in patients cured of malignancy.","volume":"153","author":"Cesaro","year":"1994","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-3476(95)70135-4","article-title":"Response to interferon therapy in children with chronic hepatitis C.","volume":"127","author":"Fujisawa","year":"1995","journal-title":"J Pediatr"},{"key":"2021121009291030000_B18","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.1840220602","article-title":"Recombinant interferon-\u03b1 therapy in children with chronic hepatitis C.","volume":"22","author":"Bortolotti","year":"1995","journal-title":"Hepatology"},{"key":"2021121009291030000_B19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/adc.74.2.152","article-title":"Lymphoblastoid interferon-\u03b1 treatment in chronic hepatitis C.","volume":"74","author":"Iorio","year":"1996","journal-title":"Arch Dis Child"},{"key":"2021121009291030000_B20","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V87.10.4072.bloodjournal87104072","article-title":"Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia.","volume":"87","author":"Komatsu","year":"1996","journal-title":"Blood"},{"key":"2021121009291030000_B21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s004310050694","article-title":"Efficacy of interferons in treating children with chronic hepatitis C.","volume":"156","author":"Matsuoka","year":"1997","journal-title":"Eur J Pediatr"},{"key":"2021121009291030000_B22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0168-8278(88)80003-5","article-title":"Favorable response to lymphoblastoid interferon-\u03b1 in children with chronic hepatitis C.","volume":"28","author":"Sawada","year":"1998","journal-title":"J Hepatol"},{"key":"2021121009291030000_B23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0168-8278(99)80338-9","article-title":"Low virological response to interferon in children with chronic hepatitis C.","volume":"31","author":"Pensati","year":"1999","journal-title":"J Hepatol"},{"key":"2021121009291030000_B24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510260719","article-title":"Therapy of hepatitis C: alpha interferon and ribavirin.","volume":"26","author":"Reichard","year":"1997","journal-title":"Hepatology"},{"key":"2021121009291030000_B25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(97)06088-1","article-title":"Randomised, double-blind, placebo-controlled trial of interferon \u03b1-2b with and without ribavirin for chronic hepatitis C.","volume":"351","author":"Reichard","year":"1998","journal-title":"Lancet"},{"key":"2021121009291030000_B26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C.","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"2021121009291030000_B27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840200213","article-title":"A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.","volume":"20","author":"Chevallier","year":"1994","journal-title":"Hepatology"},{"key":"2021121009291030000_B28"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/4\/e53\/843162\/e53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/4\/e53\/843162\/e53.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:16:40Z","timestamp":1639171000000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/106\/4\/e53\/65837\/Interferon-and-Ribavirin-in-Treating-Children-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2000,10,1]]},"published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.106.4.e53","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"type":"electronic","value":"1098-4275"},{"type":"print","value":"0031-4005"}],"subject":[],"published":{"date-parts":[[2000,10,1]]}}}